Capital Analysts LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25K | Hold |
446
| – | – | ﹤0.01% | 956 |
|
|
2025
Q1 | $32K | Sell |
446
-71
| -14% | -$5.09K | ﹤0.01% | 879 |
|
|
2024
Q4 | $34K | Hold |
517
| – | – | ﹤0.01% | 827 |
|
|
2024
Q3 | $36K | Sell |
517
-243
| -32% | -$16.9K | ﹤0.01% | 789 |
|
|
2024
Q2 | $63K | Sell |
760
-135
| -15% | -$11.2K | ﹤0.01% | 659 |
|
|
2024
Q1 | $78K | Hold |
895
| – | – | ﹤0.01% | 588 |
|
|
2023
Q4 | $86K | Sell |
895
-105
| -11% | -$10.1K | ﹤0.01% | 555 |
|
|
2023
Q3 | $88K | Buy |
1,000
+121
| +14% | +$10.6K | ﹤0.01% | 506 |
|
|
2023
Q2 | $76K | Hold |
879
| – | – | ﹤0.01% | 515 |
|
|
2023
Q1 | $85K | Hold |
879
| – | – | ﹤0.01% | 497 |
|
|
2022
Q4 | $91K | Hold |
879
| – | – | 0.01% | 519 |
|
|
2022
Q3 | $75K | Hold |
879
| – | – | 0.01% | 492 |
|
|
2022
Q2 | $73K | Hold |
879
| – | – | 0.01% | 484 |
|
|
2022
Q1 | $68K | Sell |
879
-65
| -7% | -$5.03K | ﹤0.01% | 504 |
|
|
2021
Q4 | $83K | Buy |
+944
| New | +$83K | 0.01% | 480 |
|
|
2019
Q3 | – | Sell |
-25
| Closed | -$2K | – | 699 |
|
|
2019
Q2 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 628 |
|